A predictive model was created based on CD8 expression at the invasive margin and was validated in an independent set of 15 patients, with authors concluding that tumor regression after PD-1 blockade requires preexisting CD8+ T cells, which are negatively regulated by a PD-1/PD-L1-mediated adaptive resistance [41]. This evidence concerns the gene CD274 and neoplasm.